Get Coya Therapeutics alerts:Several equities analysts recently commented on COYA shares. Coya Therapeutics (NASDAQ:COYA – Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. On average, analysts expect that Coya Therapeutics will post -1.15 earnings per share for the current fiscal year. Coya Therapeutics Company Profile(Get Free Report)Coya Therapeutics, Inc, a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). Recommended StoriesReceive News & Ratings for Coya Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coya Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.